Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Francais d'Immunotherapie. - Negrier,S.; Escudier,B.; Lasset,C. (N Engl J Med, 1998)